Last week, the Multidisciplinary Association for Psychedelics Studies (MAPS) made a very big announcement: it had raised $30 million to complete its promising study of MDMA (ecstasy; molly) for treating post-traumatic stress disorder (PTSD). The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. With its recent cash
Search Results for psychedelics
Psilocybin (the chemical), psilocybin mushrooms, and anything containing psilocybin is illegal at the federal level and in every state in the United States. I know, I know, a few cities and the State of Oregon have decriminalized some psychedelics, but decriminalization does not create any kind of legal, regulated market. And yes, Oregon will eventually
We work with a good number of multi-state operator (MSO) cannabis companies. Always have. Most of these companies are publicly traded, although others remain closely held. With more MSOs on the scene than ever before, it seems like a good time to list out some pitfalls for MSOs, their decisionmakers, lenders, etc., as these companies
For anyone who was not able to join our Q&A webinar last week on psychedelics, we’ve got you covered! Below, please find the full webinar for your viewing pleasure. If you missed part one of this two-part webinar, you can watch it HERE.
For thousands of years, groups of people across the globe have consumed psychedelic (also referred to as entheogenic) plants as part of religious practices. In the twentieth century, many of these religious practices were outlawed by international treaties such as the Single Convention on Narcotic Drugs of 1961 and the Convention on Psychotropic Substances of
Click HERE to learn more about the second part of this webinar! On July 9th, California psychedelic attorneys Hilary Bricken (Los Angeles), Griffen Thorne (Los Angeles), Vince Sliwoski (Portland) and Jesse Mondry (Portland) hosted an interactive webinar to answer questions on the future of legalization and regulation of new drug therapies and alternative medicine, including: efforts to decriminalize and
Q: I want to study schedule I controlled substances. I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. A: All of that is possible, but you should choose just one. Q: OK, I want to study cannabis. A: That’s actually one of the hardest. Please choose a better one.
Earlier this year we wrote about the movement to decriminalize psilocybin – noting its success in Denver, Oakland, and Santa Cruz – and that nearly 100 other cities are looking at decriminalizing psychedelics. (The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)). That article posited that psilocybin would move along two tracks
Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver, and Santa Cruz have decriminalized psilocybin to varying degrees. Much like cannabis, public perception of certain psychedelics like psilocybin is shifting rapidly, as people really the incredible
On Wednesday, May 8, 2019, Denver, Colorado announced a pass result for Initiated Ordinance 301, becoming the first U.S. jurisdiction to decriminalize psilocybin-containing mushrooms. The ballot title reads as follows: Shall the voters of the City and County of Denver adopt an ordinance to the Denver Revised Municipal Code that would make the personal use